Study Examines Fatty Acids and Receptors in Type 2 Diabetes

Understanding Type 2 Diabetes

Diabetes is a metabolic disorder that impairs the body’s ability to transfer glucose from the bloodstream into cells, where it serves as an energy source. Type 2 diabetes is the most prevalent form, characterized by reduced sensitivity of body cells to insulin, the hormone responsible for glucose transport.

Current Prevention Strategies

Current strategies aimed at preventing type 2 diabetes in at-risk individuals predominantly focus on weight loss and dietary changes, particularly concerning carbohydrate intake. However, emerging research indicates that dietary fatty acids and fatty acid cell receptors, especially the sCD36 receptor, may also play a role in the onset of type 2 diabetes.

Research Overview

A team of researchers from Turkey conducted a study comparing dietary fatty acid patterns, preferences for fatty foods, and sCD36 receptor levels in individuals newly diagnosed with type 2 diabetes and healthy subjects. The findings were published in the British Journal of Nutrition.

Study Participants and Methodology

The study involved 38 participants diagnosed with type 2 diabetes and 37 healthy individuals. Each participant underwent a physical examination to gather body measurements, including weight, height, waist, and hip circumferences. Blood samples were collected and evaluated for fasting blood glucose, triglycerides, and insulin levels, as well as sCD36 receptor concentrations.

Findings on sCD36 and Metabolic Syndrome

Elevated levels of sCD36 have been identified as a marker for metabolic syndrome, which encompasses various risk factors such as high blood pressure, obesity, elevated blood glucose, and triglycerides. These factors increase the likelihood of developing heart disease, stroke, and type 2 diabetes. The researchers also assessed insulin resistance and dietary preferences through a detailed questionnaire.

Insights on Fatty Acid Consumption

Although the overall fatty acid intake did not significantly differ between the two groups, the type 2 diabetes patients reported a lower consumption of olive oil compared to the healthy group. Additionally, the type 2 diabetes group exhibited higher average levels of blood glucose, insulin, insulin resistance, triglycerides, and sCD36.

sCD36 as a Potential Biomarker

The findings indicate that elevated sCD36 levels could heighten the risk of type 2 diabetes. However, further analysis within the diabetic group revealed no direct correlation between sCD36 levels and insulin resistance, blood insulin, triglyceride levels, waist circumference, or preferences for fatty foods.

Researchers propose that sCD36 may serve as a blood biomarker for type 2 diabetes, as evidenced by its increased levels in newly diagnosed patients. Further exploration of this receptor could yield valuable insights into the underlying causes of type 2 diabetes and may present new avenues for treatment.

Conclusion

This study underscores the need for additional research into the sCD36 receptor and its implications for type 2 diabetes management and treatment strategies.

Written by: Julie McShane, Medical Writer

Reference

Ekici M, Kisa U, Durmaz S, et al. Fatty acid transport receptor soluble CD36 and dietary fatty acid pattern in type 2 diabetic patients: a comparative study. British Journal of Nutrition (2018). 119, 153-162. DOI: 10.1017/S0007114517003269.